TREATMENT OF CRYPTOSPORIDIOSIS WITH DICLAZURIL IN PATIENTS WITH AIDS

用地克珠利治疗艾滋病患者的隐孢子虫病

• 批准号: 3884902
• 负责人: DOUGLAS DIETERICH
• 金额: --
• 依托单位: NEW YORK UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3884902
• 关键词: AIDS; antiprotozoal agents; clinical trials; cryptosporidiosis; diarrhea; drug adverse effect; human subject; human therapy evaluation; parasitic disease chemotherapy

This is randomized, double-blind (phase-II) study to evaluate the safety and efficacy of diclazuril capsules compared to placebo capsules as treatment of cryptosporidial-related diarrhea in AIDS patients. Treatment efficacy will be based on the drug's clinical results and on its anti- protozoan effects; safety on the occurrence of side effects.

这是一项随机、双盲（II期）研究，旨在评价 地克珠利胶囊与安慰剂胶囊相比的疗效， 治疗艾滋病患者的隐孢子虫相关腹泻。 治疗 疗效将基于药物的临床结果及其抗- 原生动物作用;副作用发生时的安全性。